SecBot SecBot
144 ·Filed Jun 26, 2026

SEPN

Septerna, Inc.
BEARISH
Impact 4/10
Horizonweeks Processed4mo ago SEC0001950047-26-006526
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

Monitor for actual execution on Form 4 and any upcoming pipeline catalysts that may offset selling pressure.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$34.75
T+0 close · Jun 26, 2026 · via day close
Latest settled
+16.20%
T+60 · $40.38
Vs SPY
+11.82%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 29 $34.75entry
  2. T+1 · 5mo ago −3.63%α −4.40% · $33.49
  3. T+5 · 4mo ago −3.68%α −5.07% · $33.47
  4. T+20 · 4mo ago −4.75%α −4.47% · $33.10
  5. T+60 · 8w ago +16.20%α +11.82% · $40.38
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Jae B. Kim, an officer of Septerna, Inc., filed a Form 144 on June 26, 2026, indicating intent to sell 94,339 shares of common stock, with an approximate market value of $3.33 million based on the filing date. This is a non-urgent intent filing, but the sell size relative to recent insider activity carries negative signal.

Key Facts

  • Form 144 filed by officer Jae B. Kim on 2026-06-26 for 94,339 shares of SEPN common stock.
  • Estimated market value of proposed sale: approximately $3.33 million ($35.26 per share).
  • Prior 30-day insider activity includes 3 sells totaling $547,000, so this filing more than quintuples known insider selling volume.
  • Shares to be sold were acquired via employee stock purchase plans (10/31/2025 and 04/30/2026), not open-market buys.

Financial Impact

Proposed insider sale of ~$3.33M in SEPN stock (0.21% of $1.6B market cap).

Risk Factors

  • Insider sale may signal reduced conviction ahead of key clinical or operational milestones.
  • If sale executes, near-term technical overhang of ~94k shares could pressure the stock.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-006526
Document: 0001950047-26-006526-index.html0001950047-26-006526
Document: 0001950047-26-006526.txt0001950047-26-006526

US Market Status

Market Closed · Opens Wed (11h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 26, 2026